Bollywood actors Deepika Padukone, Shraddha Kapoor and Sara Ali Khan at the NCB office for questioning in a drug probe related to late actor Sushant Singh Rajput

After Deepika Padukone, Sara Ali Khan, ‘bigger, more influential Bollywood names to tumble out’ amid NCB probe: report

Bigger and extra influential names will quickly tumble out amid the Narcotics Control Bureau’s investigation into the alleged medication nexus in Bollywood. So far, actors Deepika Padukone, Shraddha Kapoor, Sara Ali Khan and Rakul Preet Singh have been summoned by the NCB for questioning.

The actors names got here up within the NCB’s investigation of Rhea Chakraborty’s connections to drug suppliers. Rhea was initially being investigated in connection along with her boyfriend, Sushant Singh Rajput’s demise.

According to Republic, sources have mentioned that the upcoming part of the investigation is predicted to final a month, and can contain a number of of the ‘biggest names in Bollywood’. Over the weekend, it was reported {that a} former Dharma Productions worker being questioned within the case was pressured to implicate Karan Johar, in change of immunity. The NCB denied the cost.

Also learn: Producer Kshitij Prasad alleges NCB pressured him to implicate Karan Johar in medication probe, company denies cost: report

In an announcement final week, Karan had distanced himself from Kshitij Prasad, explaining how he didn’t know him personally. He had added that Kshitij had solely briefly been employed by Karan’s Dharmatic Entertainment, a sister concern of Dharma Productions, in 2019.

“The statements of Karishma Prakash, Sara Ali Khan, Deepika Padukone and Shraddha Kapoor have been recorded. Kshitij Prasad has been placed under arrested after questioning. No fresh summon has been issued today. We have arrested more than 18 people,” Mutha Ashok Jain, Deputy DG, South-Western Region of NCB mentioned on Saturday.

Also learn: Deepika Padukone, Sara Ali Khan, Shraddha Kapoor’s telephones seized by NCB

The NCB had launched an investigation into the medication case after it obtained official communication from the Enforcement Directorate (ED), which was investigating the cash path associated to actor Sushant Singh Rajput’s demise case.

Follow @India_NewsLive for extra